Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2014, Article ID 835716, 10 pages
http://dx.doi.org/10.1155/2014/835716
Review Article

Lifestyle Factors in Hypertension Drug Research: Systematic Analysis of Articles in a Leading Cochrane Report

1Allan McGavin Sports Medicine Centre, University of British Columbia, Vancouver, BC, Canada V6T 1Z3
2Father David Bauer Clinic (Centric Health Corporation), Calgary, AB, Canada T2N 3Y9
3CBI Health Centre, Duncan, BC, Canada V9L 1N8
4Squamish Physio & Wellness Centre, Squamish, BC, Canada V8B 0B4
5Movéo Sport and Rehabilitation Centre, North Vancouver, BC, Canada V7L 2P7
6Department of Physical Therapy, Faculty of Medicine, University of BC, Vancouver, BC, Canada V6T 1Z3

Received 12 August 2013; Revised 12 November 2013; Accepted 26 November 2013; Published 28 January 2014

Academic Editor: Kazuomi Kario

Copyright © 2014 Dan E. Wilson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Established standards for first-line hypertension management include lifestyle modification and behavior change. The degree to which and how lifestyle modification is systematically integrated into studies of first-line drug management for hypertension is of methodological and clinical relevance. This study systematically reviewed the methodology of articles from a recent Cochrane review that had been designed to inform first-line medical treatment of hypertension and was representative of high quality established clinical trials in the field. Source articles were systematically reviewed for lifestyle interventions including smoking cessation, diet, weight loss, physical activity and exercise, stress reduction, and moderate alcohol consumption. 54% of articles did not mention lifestyle modification; 46% contained nonspecific descriptions of interventions. We contend that hypertension management research trials (including drug studies) need to elucidate the benefits and risks of drug-lifestyle interaction, to support the priority of lifestyle modification, and that lifestyle modification, rather than drugs, is seen by patients and the public as a priority for health professionals. The inclusion of lifestyle modification strategies in research designs for hypertension drug trials could enhance current research, from trial efficacy to clinical outcome effectiveness, and align hypertension best practices of a range of health professionals with evidence-based knowledge translation.